Head, Commercial BD Assessments at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor’s required; advanced degree required
Extensive knowledge of the US pharmaceutical & biotech market; experience in oncology (preference for multiple myeloma); preferred experience in cell therapy
Minimum of 15-years of pharma marketing, medical, BD or strategy
An ability to work effectively with and through others; cross functional leadership
Comfort with MS Office
Comfort with analytics/modeling tools

Responsibilities

Landscape assessments – provide a thorough overview of targeted market segments, major players, market dynamics, access dynamics, etc
Market analysis – conduct comprehensive market and product analyses of targeted segments and products
Financial analysis – develop forecast and P&L models for relevant scenarios
Relationship management – effectively work across the Legend organization
Cross-functional collaboration – engage and manage stakeholder relationships in support of target opportunities
Due diligence – support organizational due diligence
Drive decision making related to project execution, including timelines, milestones and resource allocation within budget. Higher-level approvals are required for those related to significant budget allocations, strategic shifts, or major collaborations that have substantial financial or long-term implications

Skills

Key technologies and capabilities for this role

Business DevelopmentCommercial AssessmentMarket AnalysisLicensingStrategic PlanningPortfolio ManagementLifecycle PlanningCross-functional LeadershipBiotechnologyCell Therapy

Questions & Answers

Common questions about this position

What is the location for this role?

The position is based in Somerset, NJ.

What education is required for this position?

A Bachelor’s degree is required, along with an advanced degree.

What experience is needed for this role?

Candidates need extensive knowledge of the US pharmaceutical & biotech market, experience in oncology (preferably multiple myeloma), preferred experience in cell therapy, and a minimum of 15 years of experience.

What does the role involve in terms of collaboration?

The role requires working closely with R&D, BD, Corporate Strategy, and cross-functional leaders, as well as engaging and managing stakeholder relationships across the organization.

What salary or compensation does this position offer?

This information is not specified in the job description.

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free